Opportunities for selective reporting of harms in randomized clinical trials - selection criteria for non-systematic adverse events - @EvanMayoWilson Nicole Fusco, Hwanhee Hong, Tianjing Li, Joseph Canner & Kay Dickersin via #Trialsjournal: https://t.c
Interesting study on the effect of selective adverse event reporting in clinical trials. Pretty sure this also applies for medical device trials. #clinicaltrials #medicaldevices #safety https://t.co/451Mvaxlye
RT @EvanMayoWilson: REPORTING HARMS Much has been written about better reporting of harms. In our third paper (OUT NOW!), we describe some…
Opportunities for selective reporting of harms in randomized clinical trials: Selection criteria for non-systematic adverse events https://t.co/sFcy4Yj26o via @nfusco22 et al
RT @EvanMayoWilson: REPORTING HARMS Much has been written about better reporting of harms. In our third paper (OUT NOW!), we describe some…
RT @EvanMayoWilson: REPORTING HARMS Much has been written about better reporting of harms. In our third paper (OUT NOW!), we describe some…
Opportunities for selective reporting of harms in randomized clinical trials: Selection criteria for non-systematic adverse events https://t.co/GnnFLsOJ3b